Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 50, n° 4
pages 582-584 (avril 2004)
Doi : 10.1016/S0190-9622(03)02793-2
accepted : 28 May 2003
Facial psoriasis: comparison of patients with and without facial involvement

Je Young Park, MD a, Jong Hyun Rim, MD a, Yong Beom Choe, MD a, Jai Il Youn, MD, PhD a,
a Department of Dermatology, Seoul National University College of Medicine and Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea 

*Reprint requests: Jai Il Youn, MD, PhD, Department of Dermatology, Seoul National University Hospital, 28 Yonkon-Dong, Chongno-Gu, Seoul 110-744, South Korea.

Facial involvement in psoriasis has received little attention in standard descriptions of the disease because the face has long been thought of as rarely involved. A few reports have suggested that facial involvement might be a sign of severe psoriasis. However, there have been no comparison studies on the severity of psoriasis between patients with and without facial involvement.


We sought to evaluate the prevalence and characteristics of facial involvement, and to compare the severity of psoriasis between the patients with and without facial psoriasis.


A total of 282 consecutive patients with psoriasis seen in our psoriasis clinic between May 2002 and November 2002 were enrolled in this study.


Facial involvement was a marker of severe psoriasis. The face was often involved for patients with long duration or early onset of disease; with nail or joint involvement; and those requiring more extensive treatments. Patients with facial involvement were found to have more frequent pruritus, positive family history, and history of Koebner response.


Early recognition of facial psoriasis as a marker of severe disease can contribute to treatment of patients with psoriasis.

The full text of this article is available in PDF format.

 Funding sources: None.
Conflicts of interest: None identified.

© 2004  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline